In the published article, there was an error in Table 6 (Adverse events) as published. The error was found in the percentage of participants with sepsis associated with enteritis in the PEMA group. The corrected table appears below.
Table 6.
Adverse events.
| PEMA (n = 63) | OMEGA-3 (n = 63) | |
|---|---|---|
| AEs | 9 (14.3) | 3 (4.8) |
| Participants who discontinued treatment because of drug-related AE | ||
| Nausea | 1 (1.6) | 0 (0.0) |
| Pain in the extremities | 1 (1.6) | 0 (0.0) |
| Erythema on the forearm | 1 (1.6) | 0 (0.0) |
| Itching in the forearm | 1 (1.6) | 0 (0.0) |
| General malaise | 1 (1.6) | 0 (0.0) |
| Anorexia | 1 (1.6) | 0 (0.0) |
| Participants who discontinued treatment because of drug-unrelated AE | ||
| Neck stiffness | 1 (1.6) | 0 (0.0) |
| Tooth pain | 1 (1.6) | 0 (0.0) |
| Sepsis associated with enteritis | 1 (1.6) | 0 (0.0) |
| Other AEs | ||
| Worsening of glycemic control | 2 (3.2) | 1 (1.6) |
| Acute epiglottitis | 1 (1.6) | 0 (0.0) |
| Dental caries | 1 (1.6) | 0 (0.0) |
| Liver dysfunction | 1 (1.6) | 0 (0.0) |
| Muscular pain | 1 (1.6) | 0 (0.0) |
| Fall | 0 (0.0) | 1 (1.6) |
| Lumbago | 0 (0.0) | 1 (1.6) |
| Elevation of serum CK | 0 (0.0) | 1 (1.6) |
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.